Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.56 |
| ▸ | GAA | P10253 | 5/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.39 |
| ▸ | HPGD | P15428 | 6/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 2/20 | 0.35 |
| ▸ | CASP7 | P55210 | 2/20 | 0.35 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.35 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29851883 | 1.00 | KDM4E (0.56) | KDM4EGAAMAPTALDH1A1HSD17B10 | |
| SCHEMBL1509281 | 0.93 | KDM4E (0.48) | KDM4EGAAMAPTALDH1A1HSD17B10 | |
| SCHEMBL1509297 | 0.80 | KDM4E (0.35) | KDM4EGAAMAPTELANE | |
| SCHEMBL23457994 | 0.77 | SIGMAR1 (0.52) | MAPTALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL29862177 | 0.77 | SIGMAR1 (0.52) | MAPTALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL1509349 | 0.77 | ELANE (0.36) | KDM4EGAAMAPTELANE | |
| SCHEMBL1509301 | 0.76 | KDM4E (0.31) | KDM4EGAAMAPTTSHRBCHE | |
| SCHEMBL25760448 | 0.73 | ALDH1A1 (0.42) | KDM4EGAAMAPTALDH1A1HSD17B10 | |
| SCHEMBL28279 | 0.72 | MAPT (1.00) | KDM4EGAAMAPTALDH1A1HSD17B10 | |
| SCHEMBL6285846 | 0.72 | MAPT (1.00) | KDM4EGAAMAPTALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4085085-A1 | IMPROVED SHELF LIFE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS OPTICAL MATERIALS | Promerus, LLC (US) | 2022-11-09 | — | — | EP | disclosed |
| US-11230566-B2 | Shelf life mass polymerizable polycycloolefin compositions as optical materials | PROMERUS, LLC (US) | 2022-01-25 | — | — | US | disclosed |
| US-20210206789-A1 | SHELF LIFE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS OPTICAL MATERIALS | PROMERUS, LLC (US) | 2021-07-08 | — | — | US | disclosed |
| WO-2021138651-A1 | IMPROVED SHELF LIFE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS OPTICAL MATERIALS | PROMERUS, LLC (US) | 2021-07-08 | — | — | WO | disclosed |
| US-8361653-B2 | Non-aqueous electrolyte secondary battery | SHARP KABUSHIKI KAISHA (JP) | 2013-01-29 | — | — | US | disclosed |
| US-20110052982-A1 | NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | SHARP KABUSHIKI KAISHA (JP) | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210206789-A1 | SHELF LIFE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS OPTICAL MATERIALS | FOXO3, MRTO4, RRP15 | KDM4E 579/4885GAA 3508/4885MAPT 316/4885 |
| US-11230566-B2 | Shelf life mass polymerizable polycycloolefin compositions as optical materials | FOXO3, MRTO4, RRP15 | KDM4E 579/4885GAA 3508/4885MAPT 316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.